Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 272.00
-11.85 (-4.17%)
Jun 8, 2026, 4:59 PM CET
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of kr 311.78. The average 1-year stock price forecast is 14.62% higher than the current stock price, while the lowest is kr 200.00 (-26.47%) and the highest is kr 454.00 (+66.91%).
Price Target: kr 311.78 (+14.62%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 7 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 9 | 14 | 18 | 18 | 18 | 18 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 1 | 0 | 0 | 1 | 1 |
| Total | 22 | 23 | 25 | 25 | 26 | 26 |
Financial Forecast
Revenue This Year
292.40B
from 309.06B
Decreased by -5.39%
Revenue Next Year
298.89B
from 292.40B
Increased by 2.22%
EPS This Year
20.97
from 23.03
Decreased by -8.93%
EPS Next Year
21.41
from 20.97
Increased by 2.09%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 318.3B | ||
| Avg | 292.4B | ||
| Low | 272.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.0% | ||
| Avg | -5.4% | ||
| Low | -11.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.40 | ||
| Avg | 20.97 | ||
| Low | 18.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.9% | ||
| Avg | -8.9% | ||
| Low | -19.3% |